Allovir
Yahoo Finance • 8 days ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, WMPN, EMKR, ALVR on Behalf of Shareholders
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • 8 days ago
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of EMKR, CCRN, WMPN, ALVR to Act Now
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. W... Full story
Yahoo Finance • 11 days ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, SDIG, WMPN, ALVR on Behalf of Shareholders
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • 16 days ago
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of OMIC, BERY, WMPN, ALVR to Act Now
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report.... Full story
Yahoo Finance • 28 days ago
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – CYTH, ALVR, WMPN, OMC
NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. W... Full story
Yahoo Finance • 2 years ago
AlloVir to Present at the 41st Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., January 03, 2023--(BUSINESS WIRE)--AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will present at the 41st An... Full story
Yahoo Finance • 2 years ago
Final Data from AlloVir’s Phase 2 Study of Posoleucel for Multi-Virus Prevention to be Highlighted in Oral Presentation at 64th American Society of Hematology Annual Meeting
WALTHAM, Mass., November 03, 2022--(BUSINESS WIRE)--AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced that final data from the Phase 2 study of posoleucel for the prevention of cli... Full story
